Business Description
Krka d.d.
ISIN : SI0031102120
Compare
Compare
Traded in other countries / regions
KRKG.SloveniaKRK.Poland0HLK.UK IPO Date
1997-02-10Description
Krka d.d. engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 53.07 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 1482.43 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 6.28 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.5 | |||||
| 3-Year EBITDA Growth Rate | 11.8 | |||||
| 3-Year EPS without NRI Growth Rate | 12.5 | |||||
| 3-Year FCF Growth Rate | 16.8 | |||||
| 3-Year Book Growth Rate | 9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.2 | |||||
| 9-Day RSI | 42.24 | |||||
| 14-Day RSI | 46.89 | |||||
| 6-1 Month Momentum % | 18.14 | |||||
| 12-1 Month Momentum % | 10.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.01 | |||||
| Quick Ratio | 2.64 | |||||
| Cash Ratio | 1.33 | |||||
| Days Inventory | 264.92 | |||||
| Days Sales Outstanding | 88.16 | |||||
| Days Payable | 65.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.3 | |||||
| Dividend Payout Ratio | 0.7 | |||||
| 3-Year Dividend Growth Rate | 20.7 | |||||
| Forward Dividend Yield % | 5.3 | |||||
| 5-Year Yield-on-Cost % | 11.58 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 5.59 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.62 | |||||
| Operating Margin % | 25.47 | |||||
| Net Margin % | 16.39 | |||||
| FCF Margin % | 11.25 | |||||
| ROE % | 13.83 | |||||
| ROA % | 10.95 | |||||
| ROIC % | 19.3 | |||||
| ROC (Joel Greenblatt) % | 26.41 | |||||
| ROCE % | 15.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.96 | |||||
| PE Ratio without NRI | 13.24 | |||||
| Shiller PE Ratio | 15.14 | |||||
| Price-to-Owner-Earnings | 10.36 | |||||
| PEG Ratio | 0.89 | |||||
| PS Ratio | 2.12 | |||||
| PB Ratio | 1.84 | |||||
| Price-to-Tangible-Book | 1.93 | |||||
| Price-to-Free-Cash-Flow | 18.87 | |||||
| Price-to-Operating-Cash-Flow | 12.55 | |||||
| EV-to-EBIT | 9.1 | |||||
| EV-to-EBITDA | 7.05 | |||||
| EV-to-Revenue | 1.82 | |||||
| EV-to-FCF | 16.42 | |||||
| Price-to-Projected-FCF | 0.8 | |||||
| Price-to-Median-PS-Value | 1.27 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.15 | |||||
| Price-to-Graham-Number | 1.07 | |||||
| Price-to-Net-Current-Asset-Value | 3.63 | |||||
| Earnings Yield (Greenblatt) % | 11 | |||||
| FCF Yield % | 5.32 | |||||
| Forward Rate of Return (Yacktman) % | 18.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Krka d.d. Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,815.786 | ||
| EPS (TTM) (€) | 9.61 | ||
| Beta | 0 | ||
| Volatility % | 13.84 | ||
| 14-Day RSI | 46.89 | ||
| 14-Day ATR (€) | 1.994443 | ||
| 20-Day SMA (€) | 126.15 | ||
| 12-1 Month Momentum % | 10.43 | ||
| 52-Week Range (€) | 100 - 131 | ||
| Shares Outstanding (Mil) | 30.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Krka d.d. Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Krka d.d. Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Krka d.d. Frequently Asked Questions
What is Krka d.d.(XLJU:KRKG)'s stock price today?
The current price of XLJU:KRKG is €124.50. The 52 week high of XLJU:KRKG is €131.00 and 52 week low is €100.00.
When is next earnings date of Krka d.d.(XLJU:KRKG)?
The next earnings date of Krka d.d.(XLJU:KRKG) is .
Does Krka d.d.(XLJU:KRKG) pay dividends? If so, how much?
The Dividend Yield %  of Krka d.d.(XLJU:KRKG) is 5.3% (As of Today), Highest Dividend Payout Ratio of Krka d.d.(XLJU:KRKG) was 0.79. The lowest was 0.4. And the median was 0.52. The  Forward Dividend Yield % of Krka d.d.(XLJU:KRKG) is 5.3%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers